DocCheck AG (AJ91) - Net Assets

Latest as of June 2025: €38.73 Million EUR ≈ $45.28 Million USD

Based on the latest financial reports, DocCheck AG (AJ91) has net assets worth €38.73 Million EUR (≈ $45.28 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€53.98 Million ≈ $63.11 Million USD) and total liabilities (€15.25 Million ≈ $17.82 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DocCheck AG (AJ91) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	€38.73 Million
% of Total Assets	71.75%
Annual Growth Rate	4.06%
5-Year Change	27.83%
10-Year Change	103.89%
Growth Volatility	10.39

DocCheck AG - Net Assets Trend (2005–2024)

This chart illustrates how DocCheck AG's net assets have evolved over time, based on quarterly financial data. Also explore AJ91 total assets for the complete picture of this company's asset base.

Annual Net Assets for DocCheck AG (2005–2024)

The table below shows the annual net assets of DocCheck AG from 2005 to 2024. For live valuation and market cap data, see market cap of DocCheck AG.

Year	Net Assets	Change
2024-12-31	€40.08 Million ≈ $46.86 Million	+5.38%
2023-12-31	€38.03 Million ≈ $44.47 Million	-3.50%
2022-12-31	€39.41 Million ≈ $46.08 Million	+3.24%
2021-12-31	€38.18 Million ≈ $44.63 Million	+21.76%
2020-12-31	€31.35 Million ≈ $36.66 Million	+42.17%
2019-12-31	€22.05 Million ≈ $25.78 Million	+5.51%
2018-12-31	€20.90 Million ≈ $24.44 Million	+1.32%
2017-12-31	€20.63 Million ≈ $24.12 Million	+2.30%
2016-12-31	€20.17 Million ≈ $23.58 Million	+2.59%
2015-12-31	€19.66 Million ≈ $22.98 Million	+5.77%
2014-12-31	€18.59 Million ≈ $21.73 Million	+3.33%
2013-12-31	€17.99 Million ≈ $21.03 Million	+0.89%
2012-12-31	€17.83 Million ≈ $20.84 Million	-0.93%
2011-12-31	€18.00 Million ≈ $21.04 Million	-4.64%
2010-12-31	€18.87 Million ≈ $22.06 Million	+1.64%
2009-12-31	€18.57 Million ≈ $21.71 Million	+2.36%
2008-12-31	€18.14 Million ≈ $21.21 Million	-2.68%
2007-12-31	€18.64 Million ≈ $21.79 Million	-2.23%
2006-12-31	€19.06 Million ≈ $22.29 Million	+1.28%
2005-12-31	€18.82 Million ≈ $22.01 Million	--

Equity Component Analysis

This analysis shows how different components contribute to DocCheck AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 786.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	€24.69 Million	61.60%
Common Stock	€5.07 Million	12.66%
Other Comprehensive Income	€-3.21 Million	-8.00%
Other Components	€13.52 Million	33.75%
Total Equity	€40.08 Million	100.00%

DocCheck AG Competitors by Market Cap

The table below lists competitors of DocCheck AG ranked by their market capitalization.

Company	Market Cap
Airgain Inc NASDAQ:AIRG	$58.36 Million
Visang Educati KO:100220	$58.37 Million
Yonyu Plastics Co Ltd TW:1323	$58.38 Million
OneConstruction Group Limited Ordinary Shares NASDAQ:ONEG	$58.40 Million
Changhong Meiling Co Ltd B SHE:200521	$58.26 Million
Montebalito S.A. MC:MTB	$58.24 Million
Nice D&B Co. Ltd KQ:130580	$58.23 Million
Kilitch Drugs (India) Limited NSE:KILITCH	$58.23 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in DocCheck AG's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 37,332,885 to 40,079,341, a change of 2,746,456 (7.4%).
Net income of 5,283,363 contributed positively to equity growth.
Dividend payments of 2,536,908 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	€5.28 Million	+13.18%
Dividends Paid	€2.54 Million	-6.33%
Other Changes	€1.00	+0.0%
Total Change	€-	7.36%

Book Value vs Market Value Analysis

This analysis compares DocCheck AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.72x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 4.30x to 1.72x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-12-31	€3.16	€13.60	x
2006-12-31	€3.23	€13.60	x
2007-12-31	€3.22	€13.60	x
2008-12-31	€3.29	€13.60	x
2009-12-31	€3.40	€13.60	x
2010-12-31	€3.50	€13.60	x
2011-12-31	€3.32	€13.60	x
2012-12-31	€3.49	€13.60	x
2013-12-31	€3.51	€13.60	x
2014-12-31	€3.65	€13.60	x
2015-12-31	€3.87	€13.60	x
2016-12-31	€4.00	€13.60	x
2017-12-31	€4.08	€13.60	x
2018-12-31	€4.15	€13.60	x
2019-12-31	€4.39	€13.60	x
2020-12-31	€6.12	€13.60	x
2021-12-31	€7.37	€13.60	x
2022-12-31	€7.62	€13.60	x
2023-12-31	€7.37	€13.60	x
2024-12-31	€7.90	€13.60	x

Capital Efficiency Dashboard

This dashboard shows how efficiently DocCheck AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 13.18%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 9.82%
• Asset Turnover: 0.88x
• Equity Multiplier: 1.52x
Recent ROE (13.18%) is above the historical average (10.70%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	3.60%	5.97%	0.52x	1.17x	€-1.19 Million
2006	5.04%	6.94%	0.62x	1.18x	€-930.47K
2007	3.61%	4.52%	0.66x	1.21x	€-1.17 Million
2008	3.37%	3.89%	0.74x	1.17x	€-1.18 Million
2009	3.36%	3.74%	0.76x	1.18x	€-1.21 Million
2010	4.12%	4.93%	0.71x	1.17x	€-1.09 Million
2011	7.96%	7.95%	0.84x	1.19x	€-357.81K
2012	6.36%	6.05%	0.88x	1.19x	€-633.29K
2013	6.22%	6.11%	0.84x	1.21x	€-662.10K
2014	9.31%	8.51%	0.85x	1.29x	€-125.45K
2015	14.89%	10.74%	1.02x	1.36x	€946.28K
2016	13.30%	10.27%	1.01x	1.29x	€661.57K
2017	11.76%	8.59%	1.04x	1.32x	€361.09K
2018	10.92%	8.03%	1.02x	1.34x	€191.91K
2019	14.26%	9.71%	0.98x	1.49x	€937.90K
2020	29.77%	14.58%	1.34x	1.52x	€6.11 Million
2021	30.56%	13.27%	1.43x	1.61x	€7.67 Million
2022	16.31%	10.33%	0.96x	1.64x	€2.43 Million
2023	6.08%	4.25%	0.95x	1.50x	€-1.46 Million
2024	13.18%	9.82%	0.88x	1.52x	€1.28 Million

Industry Comparison

This section compares DocCheck AG's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

Industry: Health Information Services
Average net assets among peers: $36,697,048
Average return on equity (ROE) among peers: -602.93%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
DocCheck AG (AJ91)	€38.73 Million	3.60%	0.39x	$58.35 Million
CERTIVE SOLUTIONS INC. (5CE)	$-10.47 Million	0.00%	0.00x	$296.62K
IQ-AI LTD. LS -01 (5Y1)	$707.07K	-72.35%	0.70x	$144.21K
NIGHTINGALE HEALTH EO 1 (7XE)	$97.36 Million	-18.57%	0.10x	$47.63 Million
TRELLUS HEALTH LS -0006 (85Q)	$19.50 Million	-32.51%	0.04x	$159.96K
SPOTLITE360 IOT SOLUTIONS (87A0)	$295.66K	-4766.19%	10.32x	$916.43K
CompuGroup Medical SE & Co. KGaA (COP)	$28.87 Million	34.15%	3.77x	$1.17 Billion
MeVis Medical Solutions AG (M3V)	$33.73 Million	19.97%	0.35x	$45.14 Million
Nexus AG (NXU)	$123.58 Million	12.07%	0.81x	$1.24 Billion

About DocCheck AG

XETRA:AJ91 Germany Health Information Services

Market Cap

$80.67 Million

€69.00 Million EUR

Market Cap Rank

#21296 Global

#1909 in Germany

Share Price

€13.60

Change (1 day)

+3.03%

52-Week Range

€10.80 - €13.60

All Time High

€30.12